Application of molecular imaging technologies in antitumor drug development and therapy
- PMID: 25578891
- DOI: 10.2174/1381612821666150109122915
Application of molecular imaging technologies in antitumor drug development and therapy
Abstract
Molecular imaging enables noninvasive characterization, quantification and visualization of biological and pathological processes in vivo at cellular and molecular level. It plays an important role in drug discovery and development. The skillful use of molecular imaging can provide unique insights into disease processes, which greatly aid in identifications of target. Importantly, molecular imaging is widely applied in the pharmacodynamics study to provide earlier endpoints during the preclinical drug development process, since it can be applied to monitor the effects of treatment in vivo with the use of biomarkers. Herein, we reviewed the application of molecular imaging technologies in antitumor drug development process ranging from identification of targets to evaluation of therapeutic effect.
Similar articles
-
Applications of molecular imaging in drug discovery and development process.Curr Pharm Biotechnol. 2011 Apr;12(4):459-68. doi: 10.2174/138920111795163904. Curr Pharm Biotechnol. 2011. PMID: 21342108
-
Molecular imaging in drug development: Update and challenges for radiolabeled antibodies and nanotechnology.Methods. 2017 Nov 1;130:23-35. doi: 10.1016/j.ymeth.2017.07.018. Epub 2017 Jul 23. Methods. 2017. PMID: 28743635 Review.
-
Molecular Imaging in Drug Discovery and Development.Circ Cardiovasc Imaging. 2018 Feb;11(2):e005355. doi: 10.1161/CIRCIMAGING.117.005355. Circ Cardiovasc Imaging. 2018. PMID: 29449411 Free PMC article. Review.
-
Cancer and comparative imaging.ILAR J. 2014;55(1):164-8. doi: 10.1093/ilar/ilu014. ILAR J. 2014. PMID: 24936036 Review.
-
The pivotal role of multimodality reporter sensors in drug discovery: from cell based assays to real time molecular imaging.Curr Pharm Biotechnol. 2011 Apr;12(4):539-46. doi: 10.2174/138920111795163977. Curr Pharm Biotechnol. 2011. PMID: 21342103 Review.
Cited by
-
A novel natural product, britanin, inhibits tumor growth of pancreatic cancer by suppressing nuclear factor-κB activation.Cancer Chemother Pharmacol. 2020 Apr;85(4):699-709. doi: 10.1007/s00280-020-04052-w. Epub 2020 Mar 17. Cancer Chemother Pharmacol. 2020. PMID: 32185482
-
Ex Vivo and In Vivo Noninvasive Imaging of Epidermal Growth Factor Receptor Inhibition on Colon Tumorigenesis Using Activatable Near-Infrared Fluorescent Probes.Mol Imaging. 2017 Jan-Dec;16:1536012117729044. doi: 10.1177/1536012117729044. Mol Imaging. 2017. PMID: 28884622 Free PMC article.
-
Recent advancement of nanomedicine-based targeted delivery for cervical cancer treatment.Med Oncol. 2023 Nov 6;40(12):347. doi: 10.1007/s12032-023-02195-3. Med Oncol. 2023. PMID: 37930458 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources